Abstract
Although S-1 chemotherapy is used widely as postoperative adjuvant chemotherapy for gastric cancer, some patients experience diarrhea during treatment. The patient was a 39-year-old woman who underwent distal gastrectomy for gastric cancer and who had started S-1 chemotherapy as postoperative adjuvant chemotherapy 1 week before her presentation. She experienced severe diarrhea immediately after starting the course of S-1 tablets. Capsule endoscopy revealed severe S-1-induced enteritis with extensive mucosal injury in the ileum and red intestinal fluid due to the oozing of blood in the ileum. After reducing the dosage of S-1, her diarrhea became milder, and she was able to continue S-1 chemotherapy.
Keywords:
S-1-induced enteritis; chemotherapy; diarrhea; endoscopic findings.
Publication types
-
Case Reports
-
Video-Audio Media
MeSH terms
-
Adult
-
Antimetabolites, Antineoplastic / adverse effects*
-
Antimetabolites, Antineoplastic / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Capsule Endoscopy*
-
Chemotherapy, Adjuvant
-
Diarrhea / chemically induced*
-
Diarrhea / diagnostic imaging
-
Drug Combinations
-
Enteritis / chemically induced*
-
Enteritis / diagnostic imaging
-
Female
-
Gastrectomy
-
Humans
-
Oxonic Acid / adverse effects*
-
Oxonic Acid / therapeutic use
-
Severity of Illness Index
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / surgery
-
Tegafur / adverse effects*
-
Tegafur / therapeutic use
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid